Imprint
Content
Dr. Erkens Consulting Group
IndustriestraĂźe 13
D- 64380 RoĂźdorf
Germany
Tel: +49 6154 – 69 67 944 • Mobil +49 179 – 2 41 10 29
Message to Dr. Erkens Consulting Group
tax no. 73 841 210 966
Webmaster
be-sign.net • Bernd Scheurer
Mainstr. 2, 64390 Erzhausen
Tel.: +49 151 – 50 411 034
Message to Webmaster
Web:Â www.be-sign.net
Scripting
Stefan Klose
(M.Sc. Informatik)
Copyrights
Unless otherwise stated, the copyright of the photos used lies with Dr. Erkens Consulting Group.
The corresponding statutory provisions apply to all registered brands, trade names and logos used on our website, even if they are not marked as such in the respective places.
- Photo Home: ABWI74/pixabay
- Photo Business area Strategie | Consulting: Headway/unsplash
- Photo Business area Management | Leadership: Marten van den Heuvel/unsplash
- Photo Business area Analyses | Market research: Carlos Muza/unsplash
- Photo Business area Marketing | Sales: Diggity Marketing/unsplash
- Photo Business area Communication | Education: Marko Pekić/unsplash
- Photo News: Andrys/pixabay
- Photo Company: Dagobert1980/pixabay
- Photo: Meeting: jmexclusives/pixabay
- Photo: Microscope: kkolosov/pixabay
- Photo Services: paulbr74/pixabay
- Photo Network: StockSnap/pixabay
- Photo Academy: plugrafico/pixabay
- Photo Blog: Free-Photos/pixabay
- Photo: Career: rolandmey/pixabay
- Photo Contact: Skitterphoto/pixabay
- Photo MediaCenter: JESHOOTS-com/pixabay
- Photo GTC, Imprint, Privacy: Cleverpix/pixabay
Adress
Dr. Erkens Consulting Group
IndustriestraĂźe 13
64380 RoĂźdorf
Tel: +49 (0)6154 – 6967 – 944
Mobil +49 (0)179 – 2 41 10 29
info@dr-erkens-consulting.de
News
Dr. Erkens Consulting Group
- Website-Relaunch of Dr. Erkens Consulting Group
Source: Dr. Erkens Consulting Group 09/2020 - Integrated Pharma-News at Dr. Erkens Consulting Group Website
Source: Dr. Erkens Consulting Group 09/2020
Pharma Letter
- July 2024 batch of EMA/CHMP positive opinions
- M&A activity – Fuelling innovation in hard-to-treat CNS disorders
- UK to fund use of Keytruda combo in first-line cancer setting
- Approval of Leqembi in early Alzheimer’s disease rejected by CHMP
- The importance of onshoring and better control of the drug supply chain
Pharma Relations
Pharma Times
- New gut microbiome atlas could offer better treatment for digestive disorders
- Study reveals blood proteins predict risk of developing many diverse diseases
- MRC grants researcher ÂŁ1.2m to further understand complex secretory processes
- KCL study finds cell ageing could reveal early signs of neurodegenerative disease
- Study suggests targeting amyloid beta production could be promising in AD
PZ online
- Virale Interferenz: Erkältungen könnten Long-Covid-Rückfälle auslösen
- Apotheken-Reformgesetz: SPD-Minister auf Distanz zu Lauterbach
- Mit 78 Jahren : Im Rentenalter eine Apotheke ĂĽbernehmenÂ
- EMA: Keine Empfehlung für Alzheimer-Antikörper Lecanemab
- Herz-Kreislauf-Erkrankungen: Bei Präventionsthemen sind EU-Minister im Einklang
Our Place on Earth
![BigMapDec](https://www.dr-erkens-consulting.de/wp-content/uploads/2022/09/BigMapDec.jpg)
Kartenbild: OpenStreetMap, ODbL 1.0